ERS/ATS statement on interventional pulmonology. European respiratory society/American thoracic society

…, M Noppen, J Strausz, TG Sutedja… - The European …, 2002 - pubmed.ncbi.nlm.nih.gov
… 1 , PN Mathur, JF Beamis, HD Becker, S Cavaliere, H Colt, JP Diaz-Jimenez, JF Dumon,
E Edell, KL Kovitz, HN Macha, AC Mehta, M Marel, M Noppen, J Strausz, TG Sutedja; …

Therapeutic bronchoscopy with immediate effect: laser, electrocautery, argon plasma coagulation and stents

CT Bolliger, TG Sutedja, J Strausz… - European Respiratory …, 2006 - Eur Respiratory Soc
Minimally invasive diagnostic and therapeutic approaches in medicine have been applied
for a more selective and tailored approach to reduce patients' morbidity and mortality. The …

[HTML][HTML] Exhaled breath analysis for lung cancer

AG Dent, TG Sutedja, PV Zimmerman - Journal of thoracic disease, 2013 - ncbi.nlm.nih.gov
Early diagnosis of lung cancer results in improved survival compared to diagnosis with
more advanced disease. Early disease is not reliably indicated by symptoms. Because …

The natural course of preneoplastic lesions in bronchial epithelium

…, EJ Risse, PE Postmus, TG Sutedja - Clinical cancer …, 2005 - AACR
… Venmans BJ, Linden van der JC, Boxem van AJ M, Postmus PE, Smit EF, Sutedja TG. Early
detection of preinvasive lesions in high-risk patients: a comparison of conventional flexible …

Radiographically occult lung cancer treated with fibreoptic bronchoscopic electrocautery: a pilot study of a simple and inexpensive technique

…, RP Golding, PE Postmus, TG Sutedja - European …, 1998 - Eur Respiratory Soc
The curative potential of bronchoscopic intervention, eg photodynamic therapy (PDT) and
brachytherapy, for resectable radiographically occult lung cancer has been reported previously…

Outcome of bronchial carcinoma in situ

…, TJM van Boxem, EF Smit, PE Postmus, TG Sutedja - Chest, 2000 - Elsevier
Introduction The proportion of patients with carcinoma in situ in whom invasive cancer will
develop is not known. It is important for clinical decision making to know the outcome of these …

Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis

RHJ Breuer, PJF Snijders, EF Smit, TG Sutedja… - Neoplasia, 2004 - Elsevier
Polycomb group (PcG) genes are responsible for maintenance of cellular identity and
contribute to regulation of the cell cycle. Recent studies have identified several PcG genes as …

Bronchoscopic therapy in patients with intraluminal typical bronchial carcinoid

TG Sutedja, AJ Schreurs, RG Vanderschueren, B Kwa… - Chest, 1995 - Elsevier
Objective To study the efficacy of bronchoscopic therapy in patients with intraluminal typical
bronchial carcinoid. Design Retrospective analysis of the data of patients with bronchial …

Cost-effectiveness of video-assisted thoracoscopic surgery versus conservative treatment for first time or recurrent spontaneous pneumothorax

FM Schramel, TG Sutedja, JC Braber… - European …, 1996 - Eur Respiratory Soc
The aim of this study was to analyse differences in efficacy and costs in treating first time or
recurrent spontaneous pneumothorax by conservative therapy (pleural drainage or …

Long-term follow-up after first-line bronchoscopic therapy in patients with bronchial carcinoids

HAP Brokx, MA Paul, PE Postmus, TG Sutedja - Thorax, 2015 - thorax.bmj.com
Background Carcinoid of the lung is considered to be a low-grade malignancy. A subgroup
presents as an endobronchial tumour. Surgical resection is considered the standard …